Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.…
Astrazeneca (AZN) closed the most recent trading day at $71.93, moving -1.24% from the previous trading session.…
2 June 2025
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds…
DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient selection and making…
Extending the more-than-4% slide that they experienced last week, shares of Tempus AI (NASDAQ: TEM) have suffered an even more…
…
Shares of Tempus AI (NASDAQ: TEM) are falling on Wednesday. One of Cathie Woods largest holdings, the companys stock plummeted…
Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.…
AstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study.…
…
· AstraZeneca, Ericsson, Saab, SEB and Wallenberg Investments to tap new sovereign AI infrastructure
· NVIDIA to open AI…
AstraZeneca CEO gains shares under performance plan…
Visa, AstraZeneca, Shell, Ocean Power Technologies and Wheeler Real Estate Investment Trust are part of the Zacks top Analyst Blog.…
AZNs key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales in 2025.…
Todays Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN) and Shell…
FTSE starts higher Traders hopeful after US-China talks Miners rally Drug makers tumble on Trump post AstraZeneca falls 5% GSK…
FTSE starts higher Traders hopeful after US-China talks Drug makers tumble on Trump post AstraZeneca falls 5% GSK down 3%…
FTSE starts higher Traders hopeful after US-China talks Miners rally Drug makers tumble on Trump post AstraZeneca falls 5% GSK…
The consensus price target hints at a 27.9% upside potential for Astrazeneca (AZN). While empirical research shows that this sought-after…
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Roche auf "Underweight" mit einem Kursziel von 220 Franken belassen. Dass…
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Roche auf "Underweight" mit einem Kursziel von 220 Franken belassen. Dass…
AstraZeneca has opened its first U.S.-operated cell therapy manufacturing facility in Rockville, Maryland, as part of its ongoing $3.5 billion…
When it comes to shares of Tempus AI (NASDAQ: TEM), many may feel like theyre standing on a dock watching…
1 May 2025
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…
(neu: Schlusskurs)
CAMBRIDGE (dpa-AFX) - Beim Pharmakonzern Astrazeneca wird ein unerwartet starker…
(neu: Schlusskurs) CAMBRIDGE (dpa-AFX) - Beim Pharmakonzern Astrazeneca wird ein unerwartet starker Gewinnsprung zum Jahresstart durch…
CAMBRIDGE (dpa-AFX) - Beim Pharmakonzern Astrazeneca wird ein unerwartet starker Gewinnsprung zum Jahresstart durch eine drohende Millionenstrafe in China…
CAMBRIDGE (dpa-AFX) - Beim Pharmakonzern Astrazeneca wird ein unerwartet starker Gewinnsprung zum Jahresstart durch eine…
…
The chief executive of AstraZeneca said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the…
The FTSE 100 crept into positive territory in early trade on Tuesday before turning marginally negative as investors digested a…
AstraZeneca shares fall as revenue miss tempers strong Q1 earnings…
CAMBRIDGE (dpa-AFX) - Beim Pharmakonzern Astrazeneca florieren weiterhin die Geschäfte insbesondere mit Krebsmedikamenten und biotechnologisch…
Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS are included in this Analyst Blog.…
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca executive and Eli Lilly and…
Für den AKTIONÄR ist klar: Künstliche Intelligenz (KI) wird auch in der Forschung und Entwicklung von Medikamenten mittel- bis langfristig…
Amid a bullish backdrop for the broader market, Tempus AI (NASDAQ: TEM) stock is posting big gains Wednesday. The companys…
Shares of Tempus AI (NASDAQ: TEM) were skyrocketing 16.5% higher as of 10:39 a.m. ET on Wednesday. The big gain…
Tempus AI (NASDAQ:TEM) said on Wednesday it has signed multi-year strategic collaborations with AstraZeneca (AZN.L) and Pathos AI to co-develop…
The latest trading day saw Astrazeneca (AZN) settling at $67.87, representing a +1.45% change from its previous close.…
AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and Manufacturers…
NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca mit…
Equities are down this year because of Donald Trumps trade policies. The 47th U.S. president decided to impose steep tariffs…
Trotz aktueller Schwächephase halten Analysten an Kaufempfehlungen fest - Dividendenankündigung und Quartalszahlen im Fokus. Die AstraZeneca-Aktie zeigt sich diese Woche…
AbbVies, Rinvoq and AstraZenecas and Novartis are included in this Analyst Blog.…
11 April 2025
Results of Annual General Meeting held on 11 April 2025
AstraZeneca PLC announced the results of the voting at…
As the Nordic region’s largest healthcare market and a leading life science nation, Sweden is an attractive environment for healthtech…
The news of a likely import tariff hurt the share price of pharma giants like Novo Nordisk (NVO), Eli Lilly…
Might the tariff risk for pharmaceutical stocks be less than you think?…